 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 November 1998 | Volume 129 Issue 10 | Pages 787-796
Background: Predisposition genetic testing is now possible for many hereditary cancer syndromes, including hereditary nonpolyposis colorectal cancer. The optimal management of the elevated risk for cancer in carriers of mutations for hereditary nonpolyposis colorectal cancer is unclear.
Objective: To assess the life expectancy and quality-adjusted life expectancy benefits derived from endoscopic surveillance and prophylactic colectomy for persons who carry a mutation associated with hereditary nonpolyposis colorectal cancer.
Design: Decision analysis model. Lifetime risk for colorectal cancer, efficacy of surveillance and colectomy, stage-specific colorectal cancer mortality, and quality of life were included in the model.
Setting: Decision about a cancer prevention strategy at the time of a positive result on genetic testing.
Patients: Carriers of a mutation for hereditary nonpolyposis colorectal cancer who were 25 years of age.
Interventions: Immediate prophylactic colectomy; delayed colectomy on the basis of age, adenoma, or diagnosis of colorectal cancer; and endoscopic surveillance. Prophylactic surgical options were proctocolectomy with ileoanal anastomosis and subtotal colectomy with ileorectal anastomosis.
Measurements: Life expectancy and quality-adjusted life expectancy.
Results: All risk-reduction strategies led to large gains in life expectancy for carriers of a mutation for hereditary nonpolyposis colorectal cancer, with benefits ranging from 13.5 years for surveillance to 15.6 years for prophylactic proctocolectomy at 25 years of age compared with no intervention. The benefits of colectomy compared with surveillance decreased with increasing age and were minimal if colectomy was performed at the time of colorectal cancer diagnosis. When health-related quality of life was considered, surveillance led to the greatest quality-adjusted life expectancy benefit (3.1 years compared with proctocolectomy and 0.3 years compared with subtotal colectomy).
Conclusions: Colonoscopic surveillance is an effective method of reducing risk for cancer in carriers of a mutation for hereditary nonpolyposis colorectal cancer. The individual patient's choice between prophylactic surgery and surveillance is a complex decision in which personal preferences weigh heavily.
Author and Article Information
For author affiliations and current author addresses, see end of text.
ARTICLE
Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations
Grant Support: In part by the National Cancer Institute (5R25CA57711) and an American College of Gastroenterology Clinical Research Award (Dr. Syngal).
Requests for Reprints: Karen M. Kuntz, ScD, Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115-5924.
Current Author Addresses: Drs. Syngal, Weeks, Schrag, and Garber: Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.
This article has been cited by other articles:
|
|
 |
|
  J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes J. Clin. Oncol., October 1, 2006; 24(28): 4642 - 4660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes Ann. Surg. Oncol., October 1, 2006; 13(10): 1296 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hall and O. I. Olopade Disparities in Genetic Testing: Thinking Outside the BRCA Box J. Clin. Oncol., May 10, 2006; 24(14): 2197 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Gazelle, P. M. McMahon, U. Siebert, and M. T. Beinfeld Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies Radiology, May 1, 2005; 235(2): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Kievit, J H F M de Bruin, E M M Adang, J L Severens, J H Kleibeuker, R H Sijmons, T J Ruers, F M Nagengast, H F A Vasen, J H J M van Krieken, et al. Cost effectiveness of a new strategy to identify HNPCC patients Gut, January 1, 2005; 54(1): 97 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Olschwang, P Laurent-Puig, F Eisinger, and B Millat An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndrome Gut, January 1, 2005; 54(1): 169 - 169. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Watson, R. Ashwathnarayan, H. T. Lynch, and H. K. Roy Tobacco Use and Increased Colorectal Cancer Risk in Patients With Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Arch Intern Med, December 13, 2004; 164(22): 2429 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Provenzale and R. N. Gray Colorectal Cancer Screening and Treatment: Review of Outcomes Research J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Balmana, E M Stoffel, K M Emmons, J E Garber, and S Syngal Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes J. Med. Genet., April 1, 2004; 41(4): e44 - e44. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Calvert and H. Frucht The Genetics of Colorectal Cancer Ann Intern Med, October 1, 2002; 137(7): 603 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Cravo, A J Afonso, P Lage, C Albuquerque, L Maia, C Lacerda, P Fidalgo, P Chaves, C Cruz, and C Nobre-Leitao Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing Gut, March 1, 2002; 50(3): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. A. Vasen Clinical Diagnosis and Management of Hereditary Colorectal Cancer Syndromes J. Clin. Oncol., November 1, 2000; 18(90001): 81s - 92. [Full Text] [PDF]
|
|
|
|
|
|
E. T. Matloff, H. Shappell, K. Brierley, B. A. Bernhardt, W. McKinnon, and B. N. Peshkin What Would You Do? Specialists' Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination J. Clin. Oncol., June 12, 2000; 18(12): 2484 - 2492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Syngal Hereditary Nonpolyposis Colorectal Cancer: A Call for Attention J. Clin. Oncol., June 11, 2000; 18(11): 2189 - 2192. [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. O'Leary Molecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer JAMA, July 21, 1999; 282(3): 281 - 282. [Full Text] [PDF]
|
|
Article
